High molecular weight forms of deferoxamine: novel therapeutic agents for treatment of iron-mediated tissue injury.
Hedlund
B E
BE
Biomedical Frontiers, Inc., Minneapolis, Minnesota.
Hallaway
P E
PE
Mahoney
J R
JR
D000818:Animals; D003676:Deferoxamine / Q000737:chemistry / Q000494:pharmacology*; D005296:Ferrous Compounds / Q000633:toxicity; D007501:Iron / Q000633:toxicity*; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008954:Models, Biological; D008970:Molecular Weight
D005296:Ferrous Compounds; C020748:ferrous sulfate; D007501:Iron; D003676:Deferoxamine